| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | - | -60,300 | -90,957 | - |
| Foreign currency translation adjustment | - | 2,586 | - | - |
| Debt securities, available-for-sale, unrealized gain (loss) | - | -83 | - | - |
| Unrealized gains (loss) on available-for-sale securities | 316 | - | - | - |
| Total other comprehensive income (loss) | - | - | - | 1,986 |
| Total other comprehensive (loss) income | 343 | 2,503 | - | - |
| Comprehensive loss | -80,412 | -57,797 | - | -54,417 |
| Basic (in shares) | 55,633,718 | 54,858,982 | 54,241,619 | 52,240,000 |
| Diluted (in shares) | 55,633,718 | 54,858,982 | 54,241,619 | 52,246,000 |
| Net loss per share, basic (in dollars per share) | -1.45 | -1.1 | -1.68 | -1.08 |
| Net loss per share, diluted (in dollars per share) | -1.45 | -1.1 | -1.68 | -1.08 |
Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA)